Preparation H Rapid Relief Spray
NDC Package 0573-2890-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Preparation H Rapid Relief (lidocaine, phenylephrine hydrochloride) sprays is uses•Helps relieve the local discomfort and itching associated with hemorrhoids•For the temporary relief of pain, soreness or burning•Temporarily reduces the swelling associated with irritation in hemorrhoids•Temporarily shrinks hemorrhoidal tissue. This formulation utilizes a spray delivery system. Marketed by Haleon Us Holdings Llc, this product is identified by NDC 0573-2890 and is authorized under FDA application M015.

Identification & Billing

NDC Package Code
0573-2890-01
Package Description
107.7 g in 1 CANISTER
Product Code
0573-2890
11-Digit Billing Format
00573289001
RxNorm Crosswalk
  • RxCUI: 2590656 - lidocaine 5 % / phenylephrine hydrochloride 0.25 % Rectal Spray
  • RxCUI: 2590656 - lidocaine 50 MG/ML / phenylephrine hydrochloride 2.5 MG/ML Rectal Spray

Clinical Specifications

Proprietary Name
Preparation H Rapid Relief
Non-Proprietary Name
Lidocaine, Phenylephrine Hydrochloride
Substance Name
Lidocaine; Phenylephrine Hydrochloride
Dosage Form
Spray - A liquid minutely divided as by a jet of air or steam.
Administration Route
Topical - Administration to a particular spot on the outer surface of the body. The E2B term TRANSMAMMARY is a subset of the term TOPICAL.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Uses•Helps relieve the local discomfort and itching associated with hemorrhoids•For the temporary relief of pain, soreness or burning•Temporarily reduces the swelling associated with irritation in hemorrhoids•Temporarily shrinks hemorrhoidal tissue

Regulatory & Marketing

Labeler Name
Haleon Us Holdings Llc
Product Type
Human Otc Drug
FDA Application #
M015
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
02-01-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (0573-2890). Click a package code to view its specific billing and regulatory data.

0573-2890-02
127.6 g in 1 CANISTER

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 0573-2890-01 identifies a specific commercial package of 107.7 g in 1 canister of Preparation H Rapid Relief, a human over the counter drug labeled by Haleon Us Holdings Llc. This spray is formulated for topical use and contains lidocaine; phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Haleon Us Holdings Llc on February 01, 2022. The current certification is valid through December 31, 2026.

How is this Haleon Us Holdings Llc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 00573289001. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (4-4-2)
0573-2890-01
11-Digit CMS (5-4-2)
00573-2890-01

Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.